title: Vascular smooth-muscle-cell activation: proteomics point of view.
abstract: Vascular smooth-muscle cells (VSMCs) are the main component of the artery medial layer. Thanks to their great plasticity, when stimulated by external inputs, VSMCs react by changing morphology and functions and activating new signaling pathways while switching others off. In this way, they are able to increase the cell proliferation, migration, and synthetic capacity significantly in response to vascular injury assuming a more dedifferentiated state. In different states of differentiation, VSMCs are characterized by various repertories of activated pathways and differentially expressed proteins. In this context, great interest is addressed to proteomics technology, in particular to differential proteomics. In recent years, many authors have investigated proteomics in order to identify the molecular factors putatively involved in VSMC phenotypic modulation, focusing on metabolic networks linking the differentially expressed proteins. Some of the identified proteins may be markers of pathology and become useful tools of diagnosis. These proteins could also represent appropriately validated targets and be useful either for prevention, if related to early events of atherosclerosis, or for treatment, if specific of the acute, mid, and late phases of the pathology. RNA-dependent gene silencing, obtained against the putative targets with high selective and specific molecular tools, might be able to reverse a pathological drift and be suitable candidates for innovative therapeutic approaches.
authors.affiliation: Institute of Clinical Physiology-CNR, Pisa, Italy.
authors.forename: Antonella
authors.initials: A
authors.lastname: Cecchettini
authors.forename: Silvia
authors.initials: S
authors.lastname: Rocchiccioli
authors.forename: Claudia
authors.initials: C
authors.lastname: Boccardi
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Citti
mesh_terms: D050197:Atherosclerosis / Q000473:pathology / Q000503:physiopathology; D015415:Biomarkers / Q000378:metabolism; D003937:Diagnosis, Differential; D018450:Disease Progression; D005109:Extracellular Matrix / Q000378:metabolism; D005786:Gene Expression Regulation; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D016023:Integrins / Q000378:metabolism; D050356:Lipid Metabolism; D009131:Muscle, Smooth, Vascular / Q000166:cytology*; D032389:Myocytes, Smooth Muscle / Q000166:cytology / Q000502:physiology*; D010750:Phosphoproteins / Q000737:chemistry / Q000378:metabolism; D011499:Protein Processing, Post-Translational; D040901:Proteomics / Q000379:methods*; D015398:Signal Transduction / Q000502:physiology; D015533:Transcriptional Activation
chemical_list: D015415:Biomarkers; D016023:Integrins; D010750:Phosphoproteins